A biomarker is defined as "a trait that is objectively measured and analysed as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention" by the National Institutes of Health Biomarkers Definitions Working Group in 1998. Biomarkers are now so widely used in scientific and clinical research, as well as clinical practice, that their inclusion as primary endpoints in clinical trials is nearly unquestioned. A large subgroup of medical indicators – that is, objective signals of medical state viewed from outside the patient – that can be assessed accurately and reproducibly is referred to as a "biomarker," a portmanteau of "biological marker." Medical signals are distinct from medical symptoms, which are limited to the signs of health or illness that patients perceive. Biomarkers are objective, quantifiable aspects of biological processes by definition. They may or may not correlate with a patient's experience and sense of well-being, and it's possible to conceive measurable biological traits that don't correspond to a patient's clinical state, or whose fluctuations are undetectable and have no impact on health. It's also easy to conceive observable biological features with such wide variation among populations that they're all but useless as accurate predictors of disease or absence.
Important Alert:
X
Title : 30,000 nano implants in humans with no infections, no loosening, and no failures
Thomas J Webster, Interstellar Therapeutics, United States
Title : Cell and gene therapies in models of vascular brain disorders
Berislav V Zlokovic, University of Southern California, United States
Title : Artificial Intelligence (AI) in biomedical engineering
Hossein Hosseinkhani, Innovation Center for Advanced Technology, Matrix HT, United States
Title : 3D Bio printed cardiovascular tissue model for space based applications
Kunal Mitra, Florida Tech, United States
Title : Challenges in skeletal tissue engineering
Patrizia Ferretti, UCL Great Ormond Street Institute of Child Health, United Kingdom
Title : Human-like cancer tissue models as a drug screening platform
Karolina Valente, VoxCell BioInnovation, Canada